SCHEMBL4605598

SCHEMBL4605598

Cc1onc(-c2cccc(F)c2)c1C(=O)c1cn(C)c2cc(C(=O)O)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.45
IDH1 O75874 1/20 0.42
RORC P51449 4/20 0.41
GAA P10253 2/20 0.41
TSHR P16473 1/20 0.41
GABRA5 P31644 6/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
KMT2A Q03164 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
S1PR1 P21453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605164 0.90 GABRA5 (0.49) GPBAR1GAATSHRGABRA5MAPT
SCHEMBL4605736 0.88 RORC (0.52) GPBAR1RORCGAATSHRKMT2A
SCHEMBL4981211 0.87 GABRA5 (0.51) GABRA5KMT2A
SCHEMBL4981132 0.86 GABRA5 (0.41) GPBAR1GAATSHRGABRA5MAPT
SCHEMBL14188877 0.85 GABRA5 (0.54) GABRA5
SCHEMBL27739458 0.85 GPBAR1 (0.45) GPBAR1GAATSHRGABRA5MAPT
SCHEMBL4981836 0.84 GABRA5 (0.55) GABRA5
SCHEMBL4979472 0.83 TSHR (0.51) GAATSHRGABRA5MAPTHTT
SCHEMBL4979497 0.82 ALDH1A1 (0.49) TSHRGABRA5L3MBTL1KMT2ACYP2C9
SCHEMBL4605381 0.80 GPBAR1 (0.46) GPBAR1GAATSHRGABRA5CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101277952-A Isoxazole derivatives HOFFMANN LA ROCHE (CH) 2008-10-01 CN disclosed
EP-1937674-A1 ISOXAZOLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-07-02 EP disclosed
US-7378435-B2 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
WO-2007042420-A1 ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-04-19 WO disclosed
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives GABRA5, GABRA4, CHRNA5 GPBAR1 244/4885IDH1 1036/4885RORC 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.